Cargando…
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial
OBJECTIVES: The treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is based on remission-induction and remission-maintenance. Methotrexate is a widely used immunosuppressant but only a few studies explored its role for maintenance in AAV. This trial investigated the...
Autores principales: | Maritati, Federica, Alberici, Federico, Oliva, Elena, Urban, Maria L., Palmisano, Alessandra, Santarsia, Francesca, Andrulli, Simeone, Pavone, Laura, Pesci, Alberto, Grasselli, Chiara, Santi, Rosaria, Tumiati, Bruno, Manenti, Lucio, Buzio, Carlo, Vaglio, Augusto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634660/ https://www.ncbi.nlm.nih.gov/pubmed/29016646 http://dx.doi.org/10.1371/journal.pone.0185880 |
Ejemplares similares
-
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017) -
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives
por: Quartuccio, Luca, et al.
Publicado: (2023) -
ANCA-associated vasculitis in childhood: recent advances
por: Calatroni, Marta, et al.
Publicado: (2017) -
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020) -
Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study
por: Ysermans, Renée, et al.
Publicado: (2022)